
Analgesics in France
Description
Analgesics in France
Within analgesics in France, OTC analgesics is recording underwhelming growth in 2024, attributable to several factors. For example, 2023-2024 has been seeing lower incidence of flu and common colds compared to 2022, and for a shorter period between autumn 2023 and winter 2024 thanks to milder temperatures and reduced rainfall – consequences of climate change. Popular products such as acetaminophen are facing a rising risk of shortages; both pharmacists and their customers are inclined to overst...
Euromonitor International's Analgesics in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
26 Pages
- Analgesics in France
- Euromonitor International
- September 2024
- List Of Contents And Tables
- ANALGESICS IN FRANCE
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Analgesics beset by challenges in 2024
- Despite the popularity of acetaminophen, ibuprofen’s woes erode overall category potential
- Doliprane’s popularity consolidates Sanofi’s leadership position, while consumers fret over dearth of medical professionals
- PROSPECTS AND OPPORTUNITIES
- Self-medication on the rise, but uncertainty around pseudoephedrine dampens expectations for overall category
- Retailers and manufacturers look to avoid shortages
- Sanofi to divest itself of consumer health arm
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN FRANCE
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.